An option to report your results to appease non-modelers in your case might be 
reporting your CL values in a table with different age and weight.

Alan


-----Original Message-----
From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] Behalf Of John Mondick
Sent: Wednesday, October 24, 2007 11:18 AM
To: [email protected]
Subject: [NMusers] Reporting Modeling Results


I would like to get some feedback from the group concerning the reporting of 
modeling results. I have a Pop PK model developed from data arising from 124 
pediatric patients, age 1 to 48 months. All of the structural parameters have 
been scaled allometrically, with the median body weight used as the reference 
value. After accounting for body size, a covariate model was incorporated to 
describe maturational changes in CL for young children. The maturation of 
clearance was modeled using an exponential model proposed in:

Andersen et al. Population clinical pharmacology of children: modelling 
covariate effects. Eur J Pediatr. 2006

Two parameters are estimated as part of this model * the fractional change in 
CL for a typical one month old patient (beta - estimated to be 0.76 (0.589, 
0.96) for this analysis) and a maturational half-life (TCL - 3.82 (1.57, 6.95) 
months). CI’s are from the bootstrap.

The problem that I am running into is how to report the modeling results. It 
seems very natural to me to report the model results normalized to median body 
weight (L/h/10.4 kg^0.75). One of the study investigators disagrees with me and 
would like to report the results on a per kg basis (L/h/kg^0.75).  This seems 
to be counterintuitive to me, as I tend to think about what represents the 
“typical patient.”  It also makes no sense to me to represent the CL in a one 
kg child. The argument is that reporting in this manner makes more sense to 
clinicians and that there is no such thing as a typical child.

So in an attempt to appease the investigator, I fit the same model with no 
weight normalization. The estimated parameters are equivalent to what would be 
scaled from the weight-normalized model, but there is no covariance matrix (not 
surprising).  It becomes problematic when the bootstrap results are considered 
* beta = 0.78 (0.005, 0.995), TCL = 3.90 (0.001, 6.018). Again, this is not 
surprising given that the covariate model is not centered. 

I have attempted to make several compromises, including reporting the parameter 
estimates in both median weight-normalized terms and normalized per kg. I have 
also included scaled CL estimates for typical patients at several ages and body 
weights. This hasn’t met the approval of the investigator, who is now insisting 
that I report the model building procedure from the median weight model, but 
report scaled parameters only on a per kg basis. This is wrong in my opinion 
and is actually more confusing to someone who is trying to understand the model.

Can I get the group’s opinion on this? Am I being stubborn looking at the world 
through a modeler’s point of view?

Thanks,




John Mondick PhD
Research Assistant Professor
Division of Clinical Pharmacology and Therapeutics
The Children's Hospital of Philadelphia
Tel (267) 426-2292
FAX (215) 590-7544
Email:  [EMAIL PROTECTED]

Reply via email to